- Home
- AGMH vs BDRX Comparison
AGMH vs BDRX Comparison
Compare AGMH & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGMH | BDRX |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | Hong Kong | United Kingdom |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2M | 4.0M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | AGMH | BDRX |
|---|---|---|
| Price | $2.03 | $2.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 38.3K | ★ 981.2K |
| Earning Date | 10-10-2025 | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 16.43 | N/A |
| Revenue | ★ $48,526,743.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.10 | ★ N/A |
| Revenue Growth | ★ 18.80 | N/A |
| 52 Week Low | $1.09 | $2.06 |
| 52 Week High | $75.00 | $92.00 |
Technical Indicators
Market Signals| Indicator | AGMH | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.50 | N/A |
| Support Level | $1.93 | N/A |
| Resistance Level | $2.50 | N/A |
| Average True Range (ATR) | 0.17 | 0.00 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 20.34 | 0.00 |
Price Performance
Historical ComparisonAbout AGMH AGM Group Holdings Inc.
AGM Group Holdings Inc is an integrated technology company. The company focuses on blockchain-oriented ASIC chip design, high-end crypto miner production, and fintech technology software services. The company generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.